Literature DB >> 12208776

Production of inflammatory mediators by renal epithelial cells is insensitive to glucocorticoids.

Simone de Haij1, Andrea M Woltman, Astrid C Bakker, Mohamed R Daha, Cees van Kooten.   

Abstract

1. In the present study we investigated the effect of glucocorticoids on the activation of renal tubular epithelial cells, which are thought to play an important role in inflammatory processes in the kidney. 2. Activation of renal epithelial cells by IL-1, TNF-alpha or CD40L resulted in increased production of cytokines and chemokines. Both in the renal epithelial cell line HK-2 and in primary cultures of human proximal tubular epithelial cells (PTEC) production of IL-6, IL-8 and monocyte chemotactic protein 1 (MCP-1) was not inhibited by glucocorticoids, independent of the stimulus. 3. In contrast, dexamethasone strongly inhibited cytokine production by immortalized renal fibroblasts and an airway epithelial cell line (A549). 4. Stimulation of renal epithelial cells resulted in activation of NF-kappaB, a pivotal transcription factor in the regulation of cytokine genes, as was shown by IkappaB-alpha degradation and increased DNA-binding activity. In contrast to dexamethasone, addition of the NF-kappaB inhibitors pyrrolidine dithiocarbamate (PDTC) and n-tosyl-l-phenylalanine chloromethyl ketone (TPCK) completely abolished cytokine and chemokine production. 5. Renal epithelial cells express abundant levels of the functional glucocorticoid receptor alpha (GRalpha) isoform and low levels of the inhibitory beta isoform (GRbeta). 6. In conclusion, cytokine production by renal epithelial cells is insensitive to the inhibitory effects of glucocorticoids. The lack of dexamethasone-mediated inhibition was specific for renal epithelial cells and could not be explained by an increased expression of the glucocorticoid receptor beta isoform.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12208776      PMCID: PMC1573489          DOI: 10.1038/sj.bjp.0704866

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

Review 1.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.

Authors:  P J Barnes; M Karin
Journal:  N Engl J Med       Date:  1997-04-10       Impact factor: 91.245

Review 2.  Molecular mechanisms of anti-inflammatory action of glucocorticoids.

Authors:  A C Cato; E Wade
Journal:  Bioessays       Date:  1996-05       Impact factor: 4.345

Review 3.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.

Authors:  S Ghosh; M J May; E B Kopp
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

4.  Possible role for CD40-CD40L in the regulation of interstitial infiltration in the kidney.

Authors:  C van Kooten; J S Gerritsma; M E Paape; L A van Es; J Banchereau; M R Daha
Journal:  Kidney Int       Date:  1997-03       Impact factor: 10.612

5.  Synergistic effect of interleukin-1 and CD40L on the activation of human renal tubular epithelial cells.

Authors:  C van Kooten; X van der Linde; A M Woltman; L A van Es; M R Daha
Journal:  Kidney Int       Date:  1999-07       Impact factor: 10.612

6.  Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids.

Authors:  M John; S J Hirst; P J Jose; A Robichaud; N Berkman; C Witt; C H Twort; P J Barnes; K F Chung
Journal:  J Immunol       Date:  1997-02-15       Impact factor: 5.422

7.  Regulation of nuclear factor kappaB by corticosteroids in rat mesangial cells.

Authors:  R B Auwardt; S J Mudge; C G Chen; D A Power
Journal:  J Am Soc Nephrol       Date:  1998-09       Impact factor: 10.121

8.  IL-4 and IL-13 augment cytokine- and CD40-induced RANTES production by human renal tubular epithelial cells in vitro.

Authors:  J G Deckers; S De Haij; F J van der Woude; S W van der Kooij; M R Daha; C van Kooten
Journal:  J Am Soc Nephrol       Date:  1998-07       Impact factor: 10.121

9.  Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids.

Authors:  R I Scheinman; P C Cogswell; A K Lofquist; A S Baldwin
Journal:  Science       Date:  1995-10-13       Impact factor: 47.728

10.  Fas ligation induces apoptosis of CD40-activated human B lymphocytes.

Authors:  P Garrone; E M Neidhardt; E Garcia; L Galibert; C van Kooten; J Banchereau
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

View more
  15 in total

1.  Lysophosphatidic Acid Is a Proinflammatory Stimulus of Renal Tubular Epithelial Cells.

Authors:  Christiana Magkrioti; Georgia Antonopoulou; Dionysios Fanidis; Vaia Pliaka; Theodore Sakellaropoulos; Leonidas G Alexopoulos; Christoph Ullmer; Vassilis Aidinis
Journal:  Int J Mol Sci       Date:  2022-07-05       Impact factor: 6.208

2.  CD40 expression on human pancreatic duct cells: role in nuclear factor-kappa B activation and production of pro-inflammatory cytokines.

Authors:  O Vosters; C Beuneu; N Nagy; B Movahedi; E Aksoy; I Salmon; D Pipeleers; M Goldman; V Verhasselt
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

3.  Aldosterone activates NF-kappaB in the collecting duct.

Authors:  Valérie Leroy; Sophie De Seigneux; Victor Agassiz; Udo Hasler; Marie-Edith Rafestin-Oblin; Manlio Vinciguerra; Pierre-Yves Martin; Eric Féraille
Journal:  J Am Soc Nephrol       Date:  2008-11-05       Impact factor: 10.121

4.  Pathogenic role of NF-kappaB activation in tubulointerstitial inflammatory lesions in human lupus nephritis.

Authors:  Ling Zheng; Raja Sinniah; Stephen I-Hong Hsu
Journal:  J Histochem Cytochem       Date:  2008-02-18       Impact factor: 2.479

5.  DAX-1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X-chromosome, gene 1) selectively inhibits transactivation but not transrepression mediated by the glucocorticoid receptor in a LXXLL-dependent manner.

Authors:  Junguo Zhou; Robert H Oakley; John A Cidlowski
Journal:  Mol Endocrinol       Date:  2008-04-16

6.  Dexamethasone ameliorates renal ischemia-reperfusion injury.

Authors:  Sanjeev Kumar; David A Allen; Julius E Kieswich; Nimesh S A Patel; Steven Harwood; Emanuela Mazzon; Salvatore Cuzzocrea; Martin J Raftery; Christoph Thiemermann; Muhammad M Yaqoob
Journal:  J Am Soc Nephrol       Date:  2009-09-24       Impact factor: 10.121

7.  Inflammation compromises renal dopamine D1 receptor function in rats.

Authors:  Mohammad Asghar; Gaurav Chugh; Mustafa F Lokhandwala
Journal:  Am J Physiol Renal Physiol       Date:  2009-09-30

8.  Allostimulatory capacity of conditionally immortalized proximal tubule cell lines for bioartificial kidney application.

Authors:  Milos Mihajlovic; Lambertus P van den Heuvel; Joost G Hoenderop; Jitske Jansen; Martijn J Wilmer; Annemarie J F Westheim; Wil A Allebes; Dimitrios Stamatialis; Luuk B Hilbrands; Rosalinde Masereeuw
Journal:  Sci Rep       Date:  2017-08-02       Impact factor: 4.379

Review 9.  Nephrogenic acute respiratory distress syndrome: A narrative review on pathophysiology and treatment.

Authors:  Maryam Malek; Jalal Hassanshahi; Reza Fartootzadeh; Fatemeh Azizi; Somayeh Shahidani
Journal:  Chin J Traumatol       Date:  2017-11-24

10.  Micelle-Forming Dexamethasone Prodrug Attenuates Nephritis in Lupus-Prone Mice without Apparent Glucocorticoid Side Effects.

Authors:  Zhenshan Jia; Xiaobei Wang; Xin Wei; Gang Zhao; Kirk W Foster; Fang Qiu; Yangyang Gao; Fang Yuan; Fang Yu; Geoffrey M Thiele; Tatiana K Bronich; James R O'Dell; Dong Wang
Journal:  ACS Nano       Date:  2018-07-17       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.